The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
These Companies Have Seen Large Returns From 2020 Government Investment
Much focus on investment comes from the private sector, particularly those of the venture capitalist persuasion. But one of the biggest investors this country has is the federal government.
Unusual Options Activity Insight: Moderna
On Friday, shares of Moderna (NASDAQ:MRNA) saw unusual options activity. After the option alert, the stock price moved up to $337.8.
Moderna’s COVID-19 Shot Gets EMA’s Backing For Use In Adolescents
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of Moderna…
Clover Health Becomes Top WallStreetBets Interest Again As Stock Surges; AMC, SoFi, GameStop Other Top Trends
Clover Health Investments Corp. (NASDAQ: CLOV) has joined AMC Entertainment Holdings Inc. (NYSE: AMC) and SoFi Technologies Inc. (NASDAQ:
How Much a $1,000 Investment In Moderna Stock At the Time Of COVID-19 Vaccine Authorization Would Be Worth Today
Moderna, Inc. (NASDAQ: MRNA) shares have been on a stellar run in recent sessions amid COVID-19 induced momentum.
Johnson & Johnson’s COVID-19 Shot Is Less Effective Against Delta Variant: Study
As the Delta variant rapidly spreads across the U.S., accounting for 83% of the country's cases, a new study showed that neutralizing titers induced by Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine